United States · Finance & Insurance · USD (Millions) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Core Scientific, Inc./tx? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROA | -19.17% | 0.04% | 0.05% | 0.06% | 0.08% |
|---|---|---|---|---|---|
| Total Assets | $2,347.64M | $2,363.99M | $2,369.53M | $2,375.02M | $2,380.50M |
| Net Income | -$288.62M | $0.85M | $1.10M | $1.44M | $1.87M |
| Valuation | $626.97M | $626.41M | $814.34M | $1,058.64M | $1,376.23M |
| Stock Price | $0.045 | $0.045 | $0.0584 | $0.076 | $0.0988 |